Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results

Overview of attention for article published in European Urology, September 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news: 5 news outlets
twitter: 58 X users
facebook: 1 Facebook page

googleplus: 1 Google+ user
guideline: 2 clinical guideline sources

Readers on

mendeley: 168 Mendeley

So far, Altmetric has seen 87 X posts from 58 X users, with an upper bound of 166,368 followers.

New2Trip: Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses & Updated … https://t.co/kV4jt1eUuR

New2Trip: Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses & Updated … https://t.co/kV4jt1wvmp

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 83 additional X posts.